At Set Point Medical Weight Loss Clinic, your provider will give you detailed instructions on how to take semaglutide GLP-1
Nat Rev Endocrinol 14(2):8898
They may be able to help you find ways to manage the side effects if they dont go away on their own
The majority of side effects are temporary and fade substantially as your body adapts
Successful examples include semaglutide (168h), an oral octreotide formulation (restricted maintenance indication), and emerging candidates such as I-338 insulin (60h), which used sodium caprate (C10) in Novo Nordisks Phase II, trials ( 7.1 Application to FDA-approved and emerging peptides Table 2 applies this framework to representative FDA-approved peptides and emerging candidates, demonstrating how few molecules meet the criteria for oral feasibility and why the historical record of failure is the expected outcome rather than a surprising result
This captures the subjective experience of appetite suppression, which varies significantly between medications and across the transition period